ACET: Amendment: SEC Form SCHEDULE 13G/A filed by Adicet Bio Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for ACET
Across the 18 sessions after earlier ACET headlines, the stock closed higher 9 times and lower 9 times, with a median move of 5.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ACET | SPY |
|---|---|---|---|
| Oct 23, 2026 | Adicet Bio to Participate in Upcoming Investor Conferences | -6.8% | -0.5% |
| Oct 1, 2026 | Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) | -7.0% | +0.2% |
| Sep 28, 2026 | Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritisand 1 other headline that session | -29.6% | -0.7% |
| Sep 1, 2026 | Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Updateand 1 other headline that session | +6.4% | -0.7% |
| Aug 28, 2026 | Adicet Bio Announces FDA Clearance of IND Application for ADI-212 | +0.6% | -0.2% |
| Aug 6, 2026 | Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates | -13.4% | -0.2% |
Quantisnow market dataNASDAQ
ACET
Adicet Bio Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Get push alerts for ACET
Full ACET profile on Quantisnow Follow ACET and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time